{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:54:23Z","timestamp":1746770063773},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanxi Provincial Central Government guides local projects","award":["YDZJSX2022B012"],"award-info":[{"award-number":["YDZJSX2022B012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-024-01218-3","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T11:02:21Z","timestamp":1723201341000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between systemic lupus erythematosus and common female reproductive system malignancies"],"prefix":"10.1007","volume":"15","author":[{"given":"Cheng","family":"Sirong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Zanhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"issue":"3","key":"1218_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10159","key":"1218_CR2","first-page":"1859","volume":"392","author":"GBD 2017 DALYs and HALE Collaborators","year":"2017","unstructured":"GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2017;392(10159):1859\u2013922.","journal-title":"Lancet"},{"key":"1218_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","volume":"20","author":"L Song","year":"2018","unstructured":"Song L, Wang Y, Zhang J, et al. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis. Arthritis Res Ther. 2018;20:270.","journal-title":"Arthritis Res Ther"},{"key":"1218_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122964","volume":"10","author":"L Cao","year":"2015","unstructured":"Cao L, Tong H, Xu G, et al. Systemic lupus erythematous and malignancy risk: a meta-analysis. PLoS ONE. 2015;10: e0122964.","journal-title":"PLoS ONE"},{"key":"1218_CR5","doi-asserted-by":"publisher","first-page":"2029299","DOI":"10.1080\/2162402X.2022.2029299","volume":"11","author":"J Pol","year":"2022","unstructured":"Pol J, Paillet J, Plantureux C, et al. Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseases. Oncoimmunology. 2022;11:2029299.","journal-title":"Oncoimmunology"},{"key":"1218_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003540","volume":"95","author":"KH Yu","year":"2016","unstructured":"Yu KH, Kuo CF, Huang LH, et al. Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases. A nationwide population-based dynamic cohort study in Taiwan. Medicine. 2016;95: e3540.","journal-title":"Medicine"},{"issue":"5","key":"1218_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cac2.12283","volume":"42","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Liu H, Yang Y, et al. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China. Cancer Commun (Lond). 2022;42(5):435\u201346.","journal-title":"Cancer Commun (Lond)"},{"issue":"4","key":"1218_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.autrev.2009.07.004","volume":"9","author":"E Kiss","year":"2010","unstructured":"Kiss E, Kovacs L, Szodoray P. Malignancies in systemic lupus erythematosus. Autoimmun Rev. 2010;9(4):195\u20139.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"1218_CR9","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.semarthrit.2021.09.009","volume":"51","author":"AE Clarke","year":"2021","unstructured":"Clarke AE, Pooley N, Marjenberg Z, et al. Risk of malignancy in patients with systemic lupus erythematosus: systematic review and meta-analysis. Semin Arthritis Rheum. 2021;51(6):1230\u201341.","journal-title":"Semin Arthritis Rheum"},{"key":"1218_CR10","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/art.21955","volume":"54","author":"S Bernatsky","year":"2006","unstructured":"Bernatsky S, Boivin J, Manzi S, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2550\u20137.","journal-title":"Arthritis Rheum"},{"key":"1218_CR11","volume-title":"Systemic lupus erythematosus","author":"AA Justiz Vaillant","year":"2022","unstructured":"Justiz Vaillant AA, Goyal A, Varacallo M. Systemic lupus erythematosus. Treasure Island: StatPearls Publishing Copyright; 2022."},{"key":"1218_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/03009740252937568","volume":"31","author":"L Bjornadal","year":"2002","unstructured":"Bjornadal L, Lofstrom B, Yin L, et al. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheum. 2002;31:66\u201371.","journal-title":"Scand J Rheum"},{"key":"1218_CR13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/bjc.2011.115","volume":"104","author":"S Bernatsky","year":"2011","unstructured":"Bernatsky S, Ramsey-Goldman R, Foulkes W, et al. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis. Br J Cancer. 2011;104:1478\u201381.","journal-title":"Br J Cancer"},{"key":"1218_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","volume":"42","author":"S Bernatsky","year":"2013","unstructured":"Bernatsky S, Ramsey-Goldman R, Labrecque J, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun. 2013;42:130\u20135.","journal-title":"J Autoimmun"},{"issue":"3","key":"1218_CR15","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/cam4.1988","volume":"8","author":"J Hang","year":"2019","unstructured":"Hang J, Huang J, Zhou S, Wu L, Zhu Y, Zhu L, Zhou H, Xu K, Jiang H, Yang X. The clinical implication of CD45RA+ na\u00efve T cells and CD45RO+ memory T cells in advanced pancreatic cancer: a proxy for tumor biology and outcome prediction. Cancer Med. 2019;8(3):1326\u201335.","journal-title":"Cancer Med"},{"key":"1218_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0961203319826672","volume":"28","author":"EH Bae","year":"2019","unstructured":"Bae EH, Lim SY, Han KD, et al. Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea. Lupus. 2019;28:317\u201323.","journal-title":"Lupus"},{"key":"1218_CR17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/0961203321990106","volume":"30","author":"R Westermann","year":"2021","unstructured":"Westermann R, Zobbe K, Cordtz R, et al. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: a Danish nationwide cohort study. Lupus. 2021;30:752\u201361.","journal-title":"Lupus"},{"key":"1218_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","volume":"73","author":"S Bernatsky","year":"2014","unstructured":"Bernatsky S, Ramsey-Goldman R, Joseph L, et al. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis. 2014;73:138\u201342.","journal-title":"Ann Rheum Dis"},{"key":"1218_CR19","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1002\/art.30483","volume":"63","author":"L Dreyer","year":"2011","unstructured":"Dreyer L, Faurschou M, Mogensen M, et al. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term follow-up study in a Danish cohort. Arthritis Rheum. 2011;63:3032\u20137.","journal-title":"Arthritis Rheum"},{"key":"1218_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/BOR.0000000000000202","volume":"27","author":"GC Goobie","year":"2015","unstructured":"Goobie GC, Bernatsky S, Ramsey-Goldman R, et al. Malignancies in systemic lupus erythematosus\u2014a 2015 update. Curr Opin Rheumatol. 2015;27:454\u201360.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1218_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. \u201cMendelian Randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1\u201322.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"1218_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng J, Baird D, Borges MC, et al. Recent developments in mendelian randomization studies. Curr Epidemiol Rep. 2017;4(4):330\u201345.","journal-title":"Curr Epidemiol Rep"},{"key":"1218_CR23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7: e34408.","journal-title":"Elife"},{"issue":"12","key":"1218_CR24","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.31557\/APJCP.2018.19.12.3551","volume":"19","author":"RA Cader","year":"2018","unstructured":"Cader RA, Mei Yee AK, Yassin A, et al. Malignancy in systemic lupus erythematosus (SLE) patients. Asian Pac J Cancer Prev. 2018;19(12):3551\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"1218_CR25","first-page":"613","volume":"56","author":"H Wadstr\u00f6m","year":"2017","unstructured":"Wadstr\u00f6m H, Arkema EV, Sj\u00f6wall C, et al. Cervical neoplasia in systemic lupus erythematosus: a nationwide study. Rheumatology (Oxford). 2017;56(4):613\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"1218_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.autrev.2014.03.001","volume":"13","author":"E Zard","year":"2014","unstructured":"Zard E, Arnaud L, Mathian A, et al. Increased risk of high grade cervical squamous cell intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature. Autoimmun Rev. 2014;13:730\u20135.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"1218_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1590\/SO100-720320140005052","volume":"36","author":"TL Skare","year":"2014","unstructured":"Skare TL, da Rocha BV. C\u00e2ncer cervical e de mama em pacientes com l\u00fapus eritematoso sist\u00eamico [Breast and cervical cancer in patients with systemic lupus erythematosus]. Rev Bras Ginecol Obstet. 2014;36(8):367\u201371.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"6","key":"1218_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1191\/096120301678646128","volume":"10","author":"J Cibere","year":"2001","unstructured":"Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus. 2001;10(6):394\u2013400.","journal-title":"Lupus"},{"key":"1218_CR29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s10552-008-9151-8","volume":"19","author":"A Parikh-Patel","year":"2008","unstructured":"Parikh-Patel A, White R, Allen M, et al. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control. 2008;19:887\u201394.","journal-title":"Cancer Causes Control"},{"key":"1218_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00296-012-2426-0","volume":"33","author":"LDC Lyrio","year":"2013","unstructured":"Lyrio LDC, Grassi MFR, Santana IU, et al. Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus. Rheumatol Int. 2013;33:335\u201340.","journal-title":"Rheumatol Int"},{"issue":"11","key":"1218_CR31","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1002\/art.20616","volume":"50","author":"LS Tam","year":"2004","unstructured":"Tam LS, Chan AY, Chan PK, et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum. 2004;50(11):3619\u201325.","journal-title":"Arthritis Rheum"},{"key":"1218_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/acr.20367","volume":"63","author":"L-S Tam","year":"2011","unstructured":"Tam L-S, Chan PKS, Ho SC, et al. Risk factors for squamous intraepithelial lesions in systemic lupus erythematosus: a prospective cohort study. Arthritis Care Res. 2011;63:269\u201376.","journal-title":"Arthritis Care Res"},{"issue":"6","key":"1218_CR33","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.32604\/biocell.2023.027201","volume":"47","author":"Y Wang","year":"2023","unstructured":"Wang Y, Fan P, Feng Y, Yao X, Peng Y, et al. Clinical implication of naive and memory T cells in locally advanced cervical cancer: a proxy for tumor biology and short-term response prediction. Biocell. 2023;47(6):1365\u201375.","journal-title":"Biocell"},{"issue":"1360","key":"1218_CR34","first-page":"7","volume":"74","author":"SC Kim","year":"2015","unstructured":"Kim SC, Glynn RJ, Giovannucci E, et al. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Ann Rheum Dis. 2015;74(1360):7.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1218_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.rdc.2020.05.005","volume":"46","author":"A Ladouceur","year":"2020","unstructured":"Ladouceur A, Tessier-Cloutier B, Clarke AE, et al. Cancer and systemic lupus erythematosus. Rheum Dis Clin North Am. 2020;46(3):533\u201350.","journal-title":"Rheum Dis Clin North Am"},{"key":"1218_CR36","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/rheumatology\/ker143","volume":"50","author":"J Ji","year":"2011","unstructured":"Ji J, Liu X, Sundquist K, Sundquist J. Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology (Oxford). 2011;50:1513\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"1218_CR37","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1038\/srep05958","volume":"4","author":"PW Noble","year":"2014","unstructured":"Noble PW, Young MR, Bernatsky S, et al. A nucleolytic lupus autoantibody is toxic to BRCA2-deficient cancer cells. Sci Rep. 2014;4:5958.","journal-title":"Sci Rep"},{"key":"1218_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004385","volume":"4","author":"JE Hansen","year":"2012","unstructured":"Hansen JE, Chan G, Liu Y, et al. Targeting cancer with a lupus antibody. Sci Transl Med. 2012;4: 157ra142.","journal-title":"Sci Transl Med."},{"issue":"2","key":"1218_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.32604\/or.2023.031404","volume":"32","author":"J Wu","year":"2023","unstructured":"Wu J, Liao Q, Zhang LI, Wu S, Liu Z. TGF-\u03b2-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer. Oncol Res. 2023;32(2):373\u201391.","journal-title":"Oncol Res"},{"issue":"12","key":"1218_CR40","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/acr.24414","volume":"73","author":"S Bruera","year":"2021","unstructured":"Bruera S, Lei X, Zogala R, et al. Cervical cancer screening in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2021;73(12):1796\u2013803.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01218-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01218-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01218-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T11:42:29Z","timestamp":1723203749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01218-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01218-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"20 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}